Vasculitis is a disorder characterized by inXammation of blood vessels. Its clinical manifestations are diverse and depend on the size of the involved vessels and the organs aVected by ischemia. In some cases the disease is manifested only with symptoms and signs of systemic inXammation (e.g. fever, night sweats, fatigue). Results of laboratory tests usually indicate only the inXammatory process. It is known that radiolabeled glucose analogue 18F-Xuoro-deoxyglucose ([18F] FDG) used in positron emission tomography (PET) accumulates in both malignant and inXammatory tissue (Zhuang et al. in Radiol Clin North Am 43:121-134, 2005). We report a case of a patient with FDG-PET/CT Wndings of large-vessel vasculitis with follow-up results that convinced us to change the treatment.
no symptoms of speciWc organ damage and the physical examination was without abnormalities. Laboratory studies showed elevated ESR 100/h, C-reactive protein 192 mg/l and hypochromic anaemia with haemoglobin 97 g/l. Hepatic transaminase activity was slightly elevated, kidney function tests were normal. Infectious aetiology was not the probable cause of inXammation (no bacterial growth in urine and haemocultures, negative serological tests and PPD skin test). Thoracic radiography was without inXammatory changes. Abdominal and pelvic ultrasound imaging were unremarkable. Autoantibodies ANA, ASMA, AMA were negative. The thoracoabdominal CT scan was performed and showed 3-4 mm thickening of aorta wall, no stenosis of both superior mesenteric artery and left renal artery.
The patient was admitted with these Wndings to our department. On suspicion of autoimmune vasculitis PET/ CT scan was performed. The images were remarkable for extensive abnormal [18F]FDG accumulation along the walls of the thoracic and abdominal aorta, subclavian and axillary arteries, common carotid arteries, superior mesenteric arteries, iliac arteries and upper parts of femoral arteries ( Fig. 1) .
We initiated treatment with high-dose methylprednisolone pulse therapy of 500 mg/day and continued with 60 mg/day of oral prednisone with good clinical and laboratory eVect (no fever, decreasing of CRP). Because of large vessel changes, treatment with cyclophosphamid 50 mg/day was started as well.
Six months after the introduction of therapy (therapy at this time prednisone 20 mg, cyclophosphamid 50 mg/day), the only symptom of the patient was night sweats, the blood count was normalized, but CRP (45.90 mg/l) and ESR (38/ 70) were elevated. Follow-up PET/CT scan was performed. Abnormal [18F]FDG uptake was demonstrated in thoracic aorta, subclavian and axillary arteries but of a much lower intensity as on the baseline scan (Fig. 2) . Combination of cyclophosphamid with cyclosporine A 100 mg/day was administered, glucocorticoid treatment was continued. This therapy led to normalization of ESR and CRP with sustained remission after 2 months.
Discussion
This case illustrates an atypical clinical presentation of large-vessel vasculitis with no clinical symptoms of organ damage and without the possibility of veriWcation of suspected diagnosis with biopsy. The only symptoms of the patient were signs of systemic inXammation which are common in fever of unknown origin (FUO). The largevessel vasculitis is considered to be the cause in 17% of all FUO patients [2] .
FDG-PET is a non-invasive diagnostic method which shows the bio-distribution of positron emitter labelled radiopharmaceuticals in the body. Fluoro-deoxyglucose accumulates in tumour cells but also in inXammatory tissue due to the over-expression of glucose transporter (GLUT, mainly GLUT 1,3) and overproduction of glycolytic enzymes [3] . FDG-PET is highly eVective in detecting large-vessel vasculitis anywhere in the body and has high sensitivity (77-100%) and speciWcity (89-100) [3] . The percentage of PET scans helpful in the diagnostic process in patients with FUO varied from 41 to 69% [4] . Combination of CT and PET images has an advantage of direct correlation of pathological changes in metabolic activity with precise anatomical localization in one fusion image. The residual FDG uptake on follow-up PET/CT examination in our case correlated with laboratory and clinical activity of the disease and indicated a more intensive anti-inXammatory treatment was needed.
Conclusion
[18F]FDG-PET/CT is an eVective combination of imaging modalities in assessing the activity and extent of largevessel vasculitis with high sensitivity and speciWcity. This investigation has also been used to follow-up patients over time and to monitor response to anti-inXammatory and immunosuppressive treatment.
